東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Novel therapeutic approaches to the ...

Hopkins, Corey R.

FindBook

Google Book

Amazon

博客來

Novel therapeutic approaches to the treatment of Parkinson's disease = an overview and update /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Novel therapeutic approaches to the treatment of Parkinson's disease/ edited by Corey R. Hopkins.
其他題名:	an overview and update /
其他作者:	Hopkins, Corey R.
出版者:	Cham :Springer International Publishing : : 2016.,
面頁冊數:	vii, 151 p. :ill. (some col.), digital ;24 cm.
內容註:	Adenosine A2A Receptor Antagonists -- Targeting α-Synuclein as a Parkinson's Disease Therapeutic -- Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors.
Contained By:	Springer eBooks
標題:	Parkinson's disease - Treatment. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-39926-3
ISBN:	9783319399263

Novel therapeutic approaches to the treatment of Parkinson's disease = an overview and update /
Novel therapeutic approaches to the treatment of Parkinson's diseasean overview and update /[electronic resource] :edited by Corey R. Hopkins. - Cham :Springer International Publishing :2016. - vii, 151 p. :ill. (some col.), digital ;24 cm. - Topics in medicinal chemistry,181862-2461 ;. - Topics in medicinal chemistry ;8.

Adenosine A2A Receptor Antagonists -- Targeting α-Synuclein as a Parkinson's Disease Therapeutic -- Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors.

Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine. Therefore, the topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drugability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. In general, special volumes are edited by well known guest editors.

ISBN: 9783319399263

Standard No.: 10.1007/978-3-319-39926-3doiSubjects--Topical Terms:

1362514
Parkinson's disease
--Treatment.

LC Class. No.: RC382

Dewey Class. No.: 616.83306

Novel therapeutic approaches to the treatment of Parkinson's disease = an overview and update /
LDR:02427nmm a2200325 a 4500 001 2041144
003 DE-He213
005 20161117115046.0
006 m d
007 cr nn 008maaau
008 170118s2016 gw s 0 eng d
020 $a 9783319399263 $q (electronic bk.)
020 $a 9783319399249 $q (paper)
024 7 $a 10.1007/978-3-319-39926-3 $2 doi
035 $a 978-3-319-39926-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC382
072 7 $a PSB $2 bicssc
072 7 $a SCI013020 $2 bisacsh
082 0 4 $a 616.83306 $2 23
090 $a RC382 $b .N937 2016
245 0 0 $a Novel therapeutic approaches to the treatment of Parkinson's disease $h [electronic resource] : $b an overview and update / $c edited by Corey R. Hopkins.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a vii, 151 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Topics in medicinal chemistry, $x 1862-2461 ; $v 18
505 0 $a Adenosine A2A Receptor Antagonists -- Targeting α-Synuclein as a Parkinson's Disease Therapeutic -- Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors.
520 $a Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine. Therefore, the topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drugability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. In general, special volumes are edited by well known guest editors.
650 0 $a Parkinson's disease $x Treatment. $3 1362514
650 1 4 $a Chemistry. $3 516420
650 2 4 $a Medicinal Chemistry. $3 892420
650 2 4 $a Medical Biochemistry. $3 892387
650 2 4 $a Receptors. $3 1000988
650 2 4 $a Molecular Medicine. $3 890952
650 2 4 $a Neurochemistry. $3 657592
700 1 $a Hopkins, Corey R. $3 2199680
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Topics in medicinal chemistry ; $v 8 $3 1959760
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-39926-3
950 $a Chemistry and Materials Science (Springer-11644)